Graded claim

CBG and blood pressure

What does the evidence show for CBG and blood pressure?

Through potent α2-adrenoceptor agonism, CBG may influence blood pressure and heart rate; magnitude and clinical relevance in humans are uncharacterized. Basis of the consumer blood-pressure safety note.

What reaching the next rung would take

Any one of these, on top of what our registry already holds:

  • one in-vitro / laboratory effect study
  • one animal (preclinical) effect study from a research group not already counted here

The grade weighs the claim as a whole, across every study our registry holds on the question. How good any one of those papers is remains a separate matter, and you can judge each on its own terms.

Permalink

Studies behind this grade

2010

Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist

Cascio et al. · British Journal of Pharmacology · PMID 20002104 · study type: In vitro

in vitro / ex vivo (GTPgammaS, vas deferens) · in-vitro

PubMed →

Other conditions we cover

The CBG monograph covers the compound end to end, and the gap-map charts the questions nobody has tested yet.

CBG acts on α2-adrenoceptors, which help regulate blood pressure; anyone taking cardiovascular medication should consult a clinician before using CBG products. Nothing on this page is medical advice, and no statement here is a claim that CBG treats, cures, or prevents any condition. Grades are based on the studies we had checked as of 9 August 2026. Report a safety event. Peregrine Biopharma funds the platform and holds no editorial authority.